Published in Clinical Trials Week, October 20th, 2008
As previously announced, Poniard plans to use the proceeds for general corporate purposes, as well as to fund the ongoing Phase 3 SPEAR clinical trial of picoplatin,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.